Stereotaxis Total Long Term Liabilities 2010-2024 | STXS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Stereotaxis total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Stereotaxis total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$236.9B
Intuitive Surgical (ISRG)	$174.1B
Alcon (ALC)	$48.5B
IQVIA Holdings (IQV)	$44.6B
IDEXX Laboratories (IDXX)	$42.6B
Edwards Lifesciences (EW)	$40.5B
DexCom (DXCM)	$28.8B
STERIS (STE)	$23.6B
SONOVA HOLDING (SONVY)	$21B
Waters (WAT)	$20.1B
Hologic (HOLX)	$19.1B
Sysmex ADR (SSMXY)	$12.5B
Fresenius Medical Care AG KGaA (FMS)	$12.2B
Teleflex (TFX)	$11.6B
Globus Medical (GMED)	$9.6B
Penumbra (PEN)	$7.8B
Glaukos (GKOS)	$7.1B
Masimo (MASI)	$5.9B
TransMedics (TMDX)	$5.5B
Integer Holdings (ITGR)	$4.4B
PROCEPT BioRobotics (PRCT)	$4.3B
Tandem Diabetes Care (TNDM)	$2.9B
LivaNova (LIVN)	$2.8B
Veracyte (VCYT)	$2.7B
Inari Medical (NARI)	$2.6B
Elekta AB (EKTAY)	$2.5B
Nihon Kohden (NHNKY)	$2.3B
RxSight (RXST)	$2B
Integra LifeSciences Holdings (IART)	$1.4B
Pulse Biosciences (PLSE)	$1.1B